Relmada Therapeutics, Inc. RLMD Deferred Tax Assets, Gross
Deferred Tax Assets, Gross at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGross.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s deferred tax assets, gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s deferred tax assets, gross?
- Relmada Therapeutics, Inc. (RLMD) reported deferred tax assets, gross of $122.5M in Q4 2025.